Alixia
ActiveTargeting the Tumor Ecosystem to address cancer drug resistance.
What it does
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Its site says now · captured 2026-08-23
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives
Next to it in Healthcare and bio · oncology drug discovery
- Known MedicineY Combinator S20
Combining 3D cell culture & AI to translate drugs to clinical success
- Rosebud BiosciencesY Combinator W22
Growing micro-organs to find new drugs
- Talus BioY Combinator S21
Discovering drugs that target the DNA regulome
- Valink TherapeuticsY Combinator W21
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
- Arpeggio BioY Combinator S19
Arpeggio Bio develops drugs targeting transcription factors using AI…
- Exin TherapeuticsY Combinator W25
AI drug discovery platform for neurotherapeutics
- Intrinsic Medicine (fka Lupa Bio)SOSV SOSV IndieBio 09
Developing the next generation of essential, disease-modifying medicines
- Civetbio500 Global
Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics. The company's service includes a microbiota bank, a clinical intervention platform, and core big data technology that powers their bioinformatics pipeline, enabling researchers to characterize the Asian gut microbiome and understand the varying profiles across country regions.